What is Ganga Pharmaceuticals Ltd (539680) share price return in the past 10 years?

Ganga Pharmaceuticals Ltd share price has declined -0.9% annually (CAGR) over the past ten years.

What is the share price of Ganga Pharmaceuticals Ltd (539680)?

Company share prices are keep on changing according to the market conditions. The current trading price of Ganga Pharmaceuticals Ltd (539680) on 12-Feb-2026 16:59:59 at 16:59 is 12.00.

What is the P/E ratio of Ganga Pharmaceuticals?

The latest standalone P/E ratio of Ganga Pharmaceuticals as of 12-Feb-2026 is 89.76.

What is the P/B ratio of Ganga Pharmaceuticals Ltd (539680)?

The latest standalone P/B ratio of Ganga Pharmaceuticals Ltd (539680) as of 12-Feb-2026 is 0.88.

What is the 52-week high and low of Ganga Pharmaceuticals Ltd (539680)?

The 52-week high of Ganga Pharmaceuticals Ltd (539680) is Rs. 14.60 and the 52-week low is Rs. 9.35.

Ganga Pharmaceuticals Ltd (539680) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Ganga Pharmaceuticals Ltd (539680)
Brand: Ganga Pharmaceuticals

Ganga Pharmaceuticals Ltd (539680)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 539680 NSE: Pharmaceuticals & Drugs | Small Cap | Ganga Pharma. Share Price

Ganga Pharmaceuticals Ltd (539680)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 539680 NSE: Pharmaceuticals & Drugs | Small Cap | Ganga Pharma. Share Price

Key Metrics

Valuation Multiples

Market Cap

₹7 Cr.

Current Price

₹12

52-Week Low / High

₹9 / 15

TTM EPS

₹0.1

TTM Sales

₹2.6 Cr.

Book Value per Share

₹13.6

P/E Ratio

89.76

Lower than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

0.88

Lower than its 5-year historical median

Price to Sales (P/S)

2.69

Higher than its 5-year historical median

EV/EBITDA

25.69

In line with its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

1.22%

Underperforms industry median

Return on Capital Employed (ROCE)

3.22%

Underperforms industry median

Return on Assets (ROA)

0.90%

Operating Profit Margin

-4.4%

Net Profit Margin

Gross Profit Margin

5.4%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-3.65%

Operating Profit Growth (1 Year)

-300%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

60%

Asset Quality

Promoter Holding

50.91%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹2 Cr.

Equity

₹5.9 Cr.

Face Value

₹10

All Time Low / High

₹5.00 / 28.49

Ganga Pharmaceuticals stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Ganga Pharmaceuticals Ltd a good quality company?

Ganga Pharmaceuticals Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Ganga Pharmaceuticals Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Ganga Pharmaceuticals Ltd vs industry peers?

Ganga Pharmaceuticals Ltd revenue CAGR is -3.04%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Ganga Pharmaceuticals Ltd?

Promoters hold 50.91% of the Ganga Pharmaceuticals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Ganga Pharmaceuticals Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -0.9% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	6.9%	6.2%	5.8%	7.3%	7.2%	3.4%	3.4%	3.4%	3.2%	3.2%	-
Value Creation Index ⓘ	-0.5	-0.6	-0.6	-0.5	-0.5	-0.8	-0.8	-0.8	-0.8	-0.8	-
Growth Parameters ⓘ
Sales ⓘ	2.6	3	3.1	3.4	3.1	2.4	2.5	2.6	2.7	2.6	3
Sales YoY Gr.	-	14.5%	1.3%	10.2%	-8.3%	-23.1%	5.1%	4%	5.8%	-3.7%	-
Adj EPS ⓘ	0.1	0.2	0.2	0.5	0.5	0.1	0.1	0.1	0.1	-0.1	0.1
YoY Gr.	-	50%	27.8%	100%	0%	-89.1%	80%	11.1%	0%	-210%	-
BVPS (₹) ⓘ	11.2	12	12.2	12.7	13.2	13.2	13.3	13.4	13.3	13.5	13.6
Adj Net Profit ⓘ	0.1	0.1	0.1	0.2	0.2	0	0	0	0.1	-0.1	0
Cash Flow from Ops. ⓘ	-1.1	0.1	0.2	0.1	-0.3	-0.2	-0.2	-0	-1.3	-0.6	-
Debt/CF from Ops. ⓘ	-2.1	46.7	8.6	16.5	-4.8	-9.8	-9.2	-45.8	-1.1	-2.5	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	0%	-3%	2%	-3.7%
Adj EPS ⓘ	-199%	-175.1%	-206.9%	-210%
BVPSⓘ	2.1%	0.4%	0.4%	1.2%
Share Price	-0.9%	9.9%	-2.6%	-9.9%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	1.3	1.5	1.9	3.7	3.6	0.4	0.7	0.7	0.8	-0.7	1
Op. Profit Mgn % ⓘ	11.5	10.2	10.5	12.5	12.6	1.4	1.7	0.2	2.1	-4.4	-0.1
Net Profit Mgn % ⓘ	1.9	2.5	3.1	5.6	6.1	0.9	1.5	1.5	1.7	-2	2.9
Debt to Equity ⓘ	0.5	0.4	0.4	0.4	0.3	0.3	0.4	0.3	0.2	0.2	0.2
Working Cap Days ⓘ	689	737	810	746	791	1,041	1,030	1,019	1,011	1,102	237
Cash Conv. Cycle ⓘ	200	244	220	143	167	230	210	198	229	264	146

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	2.63	3.01	3.05	3.36	3.08	2.37	2.49	2.59	2.74	2.64
Operating Expenses ⓘ +	2.33	2.70	2.73	2.94	2.69	2.34	2.45	2.58	2.68	2.75
Manufacturing Costs	0.50	0.10	0.14	0.18	0.05	0.02	-0.01	-0.06	-0.01	0.02
Material Costs	0.56	0.80	0.86	0.93	1.23	1.21	1.29	1.30	1.25	1.20
Employee Cost	0.06	0.16	0.18	0.32	0.05	0.03	0.04	0.18	0.18	0.18
Other Costs ⓘ	1.21	1.63	1.55	1.51	1.37	1.07	1.13	1.17	1.25	1.36
Operating Profit ⓘ	0.30	0.31	0.32	0.42	0.39	0.03	0.04	0	0.06	-0.12
Operating Profit Margin (%)	11.5%	10.2%	10.5%	12.5%	12.6%	1.4%	1.7%	0.2%	2.1%	-4.4%
Other Income ⓘ +	0.14	0.16	0.15	0.14	0.17	0.25	0.26	0.30	0.24	0.44
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.33	0.32	0.28	0.25	0.24	0.20	0.19	0.19	0.18	0.18
Depreciation ⓘ	0.04	0.04	0.06	0.05	0.05	0.05	0.05	0.06	0.05	0.05
Profit Before Tax ⓘ	0.07	0.11	0.13	0.26	0.26	0.04	0.05	0.05	0.06	0.09
Tax ⓘ	0.02	0.03	0.03	0.07	0.07	0.02	0.01	0.01	0.02	0.02
Profit After Tax	0.05	0.07	0.09	0.19	0.19	0.02	0.04	0.04	0.05	0.08
PAT Margin (%)	1.9%	2.5%	3.1%	5.6%	6.1%	0.9%	1.5%	1.5%	1.7%	3.0%
Adjusted EPS (₹)	0.1	0.2	0.2	0.5	0.5	0.1	0.1	0.1	0.1	0.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Ganga Pharma. - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	4.80	4.88	4.97	5.15	5.35	5.37	5.41	5.45	6.43	6.51
Share Capital ⓘ	4.06	4.06	4.06	4.06	4.06	4.06	4.06	4.06	4.84	4.84
Reserves ⓘ	0.74	0.81	0.91	1.09	1.29	1.31	1.35	1.39	1.59	1.67
Debt +	2.19	2.14	2.05	1.87	1.45	1.56	1.81	1.66	1.15	1.25
Long Term Debt	1.32	1.10	0.87	0.66	0.59	0.67	0.89	0.63	0.39	0.23
Short Term Debt	0.87	1.04	1.18	1.21	0.86	0.88	0.92	1.03	0.76	1.01
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.30	0.53	1.05	0.55	0.56	0.44	0.53	0.58	0.10	0.28
Others Liabilities ⓘ	0.03	0.06	0.16	0.18	0.21	0.29	0.25	0.29	0.96	0.94
Total Liabilities ⓘ	7.33	7.61	8.23	7.76	7.57	7.66	8	7.98	8.65	8.97
Fixed Assets
Net Fixed Assets ⓘ +	0.62	0.62	0.82	0.80	0.76	0.72	0.68	0.64	0.61	0.66
Gross Block	0.98	0.99	1.26	1.29	1.30	1.32	1.33	1.35	1.37	1.47
Accumulated Depreciation	0.36	0.38	0.44	0.49	0.54	0.60	0.65	0.71	0.76	0.80
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0.50	0	0	0.09	0.09	0.09	0.09	0.09	0.09	0
Inventories	1.14	1.12	1.14	1.15	1.04	1.13	1.15	1.18	1.24	1.18
Trade Receivables	0.94	1.25	1.58	1.23	1.07	0.82	0.89	0.89	0.92	0.91
Cash Equivalents	0.22	0.55	0.29	0.24	0.01	0.01	0.02	0.03	0.03	0.30
Others Assets ⓘ	3.90	4.06	4.39	4.25	4.60	4.88	5.17	5.16	5.76	5.91
Total Assets ⓘ	7.33	7.61	8.23	7.76	7.57	7.66	8	7.98	8.65	8.97

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-1.05	0.05	0.24	0.11	-0.31	-0.18	-0.21	-0.04	-1.26	-0.58
PBT ⓘ	0.07	0.11	0.13	0.26	0.26	0.04	0.05	0.05	0.06	0.09
Adjustment ⓘ	0.04	0.19	0.18	0.15	0.11	-0.02	-0.01	-0.06	-0.01	-0.22
Changes in Working Capital ⓘ	-1.15	-0.21	-0.03	-0.23	-0.61	-0.18	-0.23	-0.02	-1.3	-0.44
Tax Paid ⓘ	-0.01	-0.04	-0.04	-0.06	-0.06	-0.01	-0.01	-0.02	-0.02	-0.01
Cash Flow From Investing Activity ⓘ +	-0.83	0.62	-0.14	0.28	0.37	0.28	0.19	0.49	0.13	1.18
Capex	-0.01	0.46	-0.26	-0.03	-0.01	-0.02	-0.01	-0.01	-0.02	-0.10
Net Investments	0	0	0	-0.09	0.21	0.04	-0.05	0.21	-0.09	1.03
Others ⓘ	-0.82	0.16	0.13	0.40	0.16	0.25	0.26	0.30	0.24	0.25
Cash Flow From Financing Activity ⓘ +	1.90	-0.33	-0.36	-0.45	-0.29	-0.10	0.03	-0.44	1.14	-0.33
Net Proceeds from Shares ⓘ	2.11	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.01	0	0	0	0	0	0	0	-0.24	-0.16
Interest Paid ⓘ	0	-0.31	-0.27	-0.24	-0.22	-0.18	-0.19	-0.19	-0.18	-0.17
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-0.23	-0.03	-0.09	-0.21	-0.07	0.08	0.22	-0.26	1.56	0
Net Cash Flow ⓘ	0.02	0.33	-0.26	-0.05	-0.22	0	0.01	0.01	0	0.27

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	1.36	1.57	1.91	3.7	3.59	0.38	0.7	0.72	0.78	1.22
ROCE (%)	6.88	6.15	5.83	7.26	7.18	3.36	3.41	3.38	3.16	3.22
Asset Turnover Ratio	0.43	0.4	0.39	0.42	0.4	0.31	0.32	0.32	0.33	0.3
PAT to CFO Conversion(x)	-21	0.71	2.67	0.58	-1.63	-9	-5.25	-1	-25.2	-7.25
Working Capital Days
Receivable Days	112.80	132.80	169.40	152.50	136.20	145.30	125.50	125.70	120.90	126.90
Inventory Days	148.40	137.20	135.30	124.60	130	167	167.40	164.60	161.70	167.70
Payable Days	240.20	67.70	222.50	313.90	164.40	149.90	136.80	155.50	99.20	57.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ganga Pharmaceuticals Ltd FAQs

The current trading price of Ganga Pharma. on 12-Feb-2026 16:59 is ₹12.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 11-Feb-2026 the market cap of Ganga Pharma. stood at ₹7.09 Cr

The latest P/E ratio of Ganga Pharma. as of 11-Feb-2026 is 89.76.

The latest P/B ratio of Ganga Pharma. as of 11-Feb-2026 is 0.88.

The 52-week high of Ganga Pharma. is ₹14.60 and the 52-week low is ₹9.35.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ganga Pharma. is ₹2.64 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Ganga Pharmaceuticals Ltd is a below average quality company.

The key valuation ratios of Ganga Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Ganga Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Ganga Pharmaceuticals Ltd

No data to display

Ganga Pharmaceuticals Ltd (539680)

Ganga Pharmaceuticals Ltd (539680)

Ganga Pharmaceuticals stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Ganga Pharma. - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ganga Pharmaceuticals Ltd FAQs

About Ganga Pharmaceuticals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Ganga Pharmaceuticals Ltd (539680)

Ganga Pharmaceuticals Ltd (539680)

Ganga Pharmaceuticals stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Ganga Pharma. - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ganga Pharmaceuticals Ltd FAQs

What is the share price of Ganga Pharma.?

What is the market cap of Ganga Pharma.?

What is the P/E ratio of Ganga Pharma.?

What is the P/B ratio of Ganga Pharma.?

What is the 52-week high and low of Ganga Pharma.?

What is the TTM revenue of Ganga Pharma.?

Is Ganga Pharmaceuticals Ltd a good quality company?

Is Ganga Pharmaceuticals Ltd undervalued or overvalued?

Is Ganga Pharmaceuticals Ltd a good buy now?

About Ganga Pharmaceuticals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.